retatrutide what does it do - GLP-1 / GIP / GCGR Tri-Agonist VisualAbstract: Retatrutide reduces body weight

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus

Srensen et al

By reducing systemic inflammation, GLP-1 may benefit individuals with chronic conditions like non-alcoholic fatty liver disease (NAFLD), rheumatoid arthritis, and even metabolic syndrome

Note that a dipeptidyl peptidase 4 (DPP-4) inhibitor can be discontinued when adding GLP-1RA because they are both incretin-based therapies and the DPP-4 inhibitor is redundant in that situation

[DOI] [PMC free article] [PubMed] [Google Scholar] 276.Chen A.S., Borden C.G., Canavan M.E., Ross J.S., Oladele C.R., Lipska K.J

Tesofensine may lead to gastrointestinal side effects such as nausea, vomiting, and diarrhea